PSA testing in Austria: Induced morbidity and saved mortality

European Journal of Cancer Prevention

Volumn 18, Issue 5, 2009, Pages 377-380

  Vutuc, Christian ^a   Waldhoer, Thomas ^a   Lunglmayr, Gerhard ^c   Hoeltl, Wolfgang ^b   Haidinger, Gerald ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Kaiser Franz Josef Spital ^*  (Austria)

^c Mistelbach General Hospital   (Austria)

Author keywords

Austria; Morbidity; Mortality; Prostate cancer; Prostate specific antigen; Screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; AUSTRIA; CANCER MORTALITY; CANCER SCREENING; GROUPS BY AGE; HUMAN; MORBIDITY; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; AUSTRIA; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MORBIDITY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 68849085519     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32832e092f     Document Type: Article

References (14)

1. Albertsen PC, Hanley JA, Fine J (2005). 20-year outcomes following conservative management of clinically localized prostate cancer. J Am Med Assoc 293:2095-2101. (Pubitemid 40617061)
2. Andriole GL, Grubb RL, Buys SS, Chia D, Church TR, Fouad MN, et al. (2009). Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360:1310-1319.
3. Barry MJ (2009). Screening for prostate cancer - the controversy that refuses to die. N Engl J Med 360:1351-1354.
4. Bartsch G, Horninger W, Klocker H, Pelzer A, Bektic J, Oberaigner W, et al. (2008). Tyrol prostate cancer demonstration project: early detection, treatment, outcome, incidence and mortality. BJU Int 101:809-816. (Pubitemid 351347736)
5. Collin SM, Martin RM, Metcalfe C, Gunnell D, Albertsen PC, Neal D, et al. (2008). Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological Study. Lancet Oncol 9:445-452.
6. Haidinger G, Madersbacher S, Schatzl G, Vutuc C (2008). Radical prostatectomies in Austria, 1997-2005. BMC Res Notes 1:48.
7. Mohamad B, Marszalek M, Brössner C, Ponholzer A,Wehrberger C,Willinger M, et al. (2007). Radical prostatectomy in Austria: a nationwide analysis of 16 524 cases. Eur Urol 51:684-689. (Pubitemid 46097260)
8. Ponholzer A, Brössner C, Struhal G, Marszalek M, Madersbacher S (2006). Lower urinary tract symptoms, urinary incontinence, sexual function and quality of life after radical prostatectomy and external beam radiation therapy: real life experience in Austria. World J Urol 24:325-330. (Pubitemid 44138188)
9. SAS (2003). SAS/STAT User's Guide. Version 9. Cary, North Carolina: SAS Institute Inc.
10. Schröder FH, Hugosson J, Roobol MJ, Tammela TLJ, Ciatto S, Nelen V, et al. (2009). Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360:1320-1328.
11. Spiegelhalter D, Thomas A, Best N, Lunn D (2004). Winbugs Version 1.4.1, User Manual. Cambridge: MRC Biostatistics Unit.
12. Vutuc C, Waldhoer T, Madersbacher S, Micksche M, Haidinger G (2001). Prostate cancer in Austria: impact of prostate-specific antigen test on incidence and mortality. Eur J Cancer Prev 10:425-428. (Pubitemid 33016253)
13. Vutuc C, Schernhammer ES, Haidinger G, Waldhoer T (2005). Prostate cancer and prostate specific antigen (PSA) screening in Austria. Wien Klin Wochenschr 117:457-461. (Pubitemid 41152495)
14. Vutuc C,Waldhoer T, Sevelda P, Micksche M, Haidinger G (2006). Self-reported prostate cancer screening in Austria. J Med Screening 13:148-151. (Pubitemid 44452727)